Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jul 14, 2022 1:49am
RE:RE:Echelon Confirms $3.75 Target
All the positive news that is being spread is being done through unofficial channels. I don't think it's totally belly up yet but had the Evotec deal been sealed a few months earlier, we would
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Jul 13, 2022 3:06pm
RE:Echelon Confirms $3.75 Target
Steadfast. Over decades I have never ever seen a penny stock move with any conviction based on a price target. We had a price target of 1 for years. It's Luke saying it will rain during a drought.
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(24)
•••
steadfast
X
View Profile
View Bullboard History
Post by
steadfast
on Jul 12, 2022 3:09pm
Echelon Confirms $3.75 Target
Echelon issued a Research Note yesterday, mainting $3.75 Target advising Via-Cyte UNLIKE , SVA, has largely demonstrated poor Clincial results to-date. $1.12 is a bargain. Expect Evotec
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on Jul 11, 2022 11:49am
RE:RE:RE:RE:Adios ViaCyte
Lol And they have the "A" team in management with Selphie Ray Matthews talking to the big investors and Frank with his Corporate experience . Pharma is waiting to pay big
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Jul 11, 2022 11:18am
RE:RE:RE:Adios ViaCyte
I think the key to Sernova being bought out is whether or not some big pharma is looking for someone to fly around the world to attend conferences and who also has connections with every pump and dump
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jul 11, 2022 11:13am
RE:RE:Adios ViaCyte
Makes you wonder what SVA is doing wrong or what Spill did to piss off Vertex enough for them to buy everyone except them. My guess is Vertex is looking at ViaCyte's immuno tech &
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on Jul 11, 2022 10:53am
RE:Adios ViaCyte
Vertex wastes money again buying another company that has a failed technology. Bode well for Sva if they can get their act together . Competeive field is reduced dramatically and if Vertex
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Jul 11, 2022 9:42am
Adios ViaCyte
https://investors.vrtx.com/news-releases/news-release-details/vertex-acquire-viacyte-goal-accelerating-its-potentially
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jul 09, 2022 3:42pm
RE:RE:RE:RE:RE:RE:RE:6 dollar target...
I didn't say that. You're confusing me with someone else.
(14)
•••
quest13
X
View Profile
View Bullboard History
Comment by
quest13
on Jul 09, 2022 10:19am
RE:RE:RE:RE:RE:RE:6 dollar target...
Hello Bio, Can you post a link to the HC Wainright write up. In your last reply to me about holdings we discussed that I by inclination am a buy and hold type of investor and you
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jul 06, 2022 2:52pm
RE:RE:RE:RE:RE:6 dollar target...
Yeah bigtime institution buying coming in based on HC report. Almost a whopping $200k worth. Must be some bigtime whales throwing that kinda cake around. Or maybe just a bakery worker.
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Jul 06, 2022 2:18pm
RE:RE:RE:RE:6 dollar target...
The idiocy of management and their incompetent IR department and firms is mind boggling.
(5)
•••
Mercuryfilling1
X
View Profile
View Bullboard History
Comment by
Mercuryfilling1
on Jul 06, 2022 2:17pm
RE:RE:RE:RE:6 dollar target...
I thought we were heading to $1.10 as well - but I guess not. With a 10% jump on a down day, someone likes HC Wainright ...or perhaps the new corporate presentation got investors all
...more
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Comment by
MustangSalley
on Jul 05, 2022 10:05pm
RE:RE:RE:6 dollar target...
HC Wainright ...are down right vultures . They finance you on one hand while their clients short you for free paper on the other hand. One of the most toxic frims out their. Even worse than
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >